Jerome Zeldis Biography and Net Worth

Jerome B. Zeldis has been a director since June 2011. Dr. Zeldis is currently Chief Medical Officer and President of Clinical Development of Sorrento Therapeutics, Inc. Previously, Dr. Zeldis was Chief Executive Officer of Celgene Global Health and Chief Medical Officer of Celgene Corporation. He was employed by Celgene from 1997 to 2016. From September 1994 to February 1997, Dr. Zeldis worked at Sandoz Research Institute and the Janssen Research Institute in both clinical research and medical development. He currently serves as Chairman of the board of Alliqua, Inc., and Trek Therapeutics, PBC, Vice Chairman of the board of MetaStat, Inc. and serves on the boards of Kalytera Therapeutics, Inc., BioSig Technologies, Inc., PTC Therapeutics, Inc., and AIT Therapeutics, Inc.  Dr. Zeldis served as Assistant Professor of Medicine at the Harvard Medical School (from July 1987 to September 1988), Associate Professor of Medicine at University of California, Davis from (September 1988 to September 1994), Clinical Associate Professor of Medicine at Cornell Medical School (January 1995 to December 2003) and Professor of Clinical Medicine at the Robert Wood Johnson Medical School (July 1998 to June 2010). Dr. Zeldis received a BA and an MS from Brown University, and an MD, and a PhD in Molecular Biophysics and Biochemistry from Yale University. Dr. Zeldis trained in Internal Medicine at the UCLA Center for the Health Sciences and in Gastroenterology at the Massachusetts General Hospital and Harvard Medical School. He has published 116 peer reviewed articles and 24 reviews, book chapters, and editorials.